Ventus Therapeutics snags Series A
Massachusetts and Montreal-based Ventus Therapeutics Inc, a biopharmaceutical company, has secured US$60 million in Series A financing.
Massachusetts and Montreal-based Ventus Therapeutics Inc, a biopharmaceutical company, has secured US$60 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination